Reference :
1 Locarnini S, Birch C. Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients. J Hepatol 1999;30:536-550.
2 Beasley RP, Stevens CE, Shiao IS, Meng HC. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975;2:740-1.
3 Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. Hepatology 2004;39:857-61.
4 Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 2002;17:643-50.
5 Thakur V, Guptan RC, Kazim SN, et al. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol 2002;17:165-70.
6 Khan M., Dong JJ., Acharya S. K. et al. Hepatology issues in Asia: Perspectives from regional leaders. Journal of Gastroenterology and Hepatology 2004;19:S419-S430
7 Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 2001;120:1828-1853.
8 Liaw YF, Leung N, Guan R, et al; for the Asian-Pacific consensus update working party on chronic hepatitis B. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int. 2005 Jun;25(3):472-89.
9 Lee PI, Chang MH, LEE CY, et al. Changes in serum hepatitis B DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children. Hepatology 1990;1:657-660.
10 Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B infection in childhood. Gastroenterology 1990;99:805-810.
11 McMahon BJ, Holck P, Bulkow H, Snowball MM. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 2001;15:759-768.
12 Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8: 493-6.
13 Weissberg JI, Andres LL, Smith CI, et al. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med 1984; 101: 613-6.
14 Beasley RP. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-56.
15 Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990; 8(Suppl.): S18-20.
16 Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991; 11: 84-92.
17 Di Bisceglie AM, Waggoner JG, Hoofnagle JH. Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers: correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy. Gastroenterology 1987;93: 1236-1241.
18 Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-1427.
19 Chu CJ, Hussain M, Lok ASF. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002;36:1408-1415.
20 Lai CL, Chien RN, Leung NW, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-68
21 Papatheodoridis GV, Hadziyannis SJ. Review article: current management of chronic hepatitis B. Aliment Pharmacol Ther. 2004 Jan 1;19(1):25-37.
22 Lok AS. The Maze of Treatments for Hepatitis B. N Engl J Med 2005;352:2743-2746.
 
23 Keeffe EB, Dieterich DT, Han SB, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004;2:87-106.
24 Guan R. Interferon monotherapy in chronic hepatitis B. J Gastroenterol Hepatol 2000;15(suppl.):E34-40.
25 Liaw YF, Lin SM, Chen TJ. Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial. J Hepatol 1994;20:175-180.

Readers' Comments

Dr. Md. Abdul Ahad
Assistant Professor, Dept. of Gastrointestinal & liver Disease
Rajshahi Medical College & Hospital.

Quarterly published Medinews on SLE is a good article. Medinews is to be continued in future with different article and topics. I wish its future development and publication.

Dr. Md. Rafiqul Hasan Faisal
Medical Officer, Jahurul Islam Medical College & Hospital
Bajitpur, Kishoregonj.

It is a very helpful for all Medical personal for upgrading their knowledge about resent improvement in medical science through GPL News. Thanks General Pharma for their contribution in spreading medical knowledge.

Dr. SK Abdullah Al-Mamoon
Oral & Dental Surgeon, Khulna.
Publishing such an informative

Medinews in just second issue is simply superb- thanks to the editorial board for helping us to rediscover the recent news and views of comprehensive health care.

Dr. Md Mizanur Rahman
Child Specialist, General Hospital, Patuakhali.

This article is very informative of helpful to me. I have enriched my knowledge. I think this "Medinews" in more helpful of informative if it is contain more articles from all faculties.

Dr. Sarwar Ibne Salam
NITOR, Sher-E- Bangla Nagar, Dhaka

The article on SLE has been an excellent one. I went through the Newsletter thoroughly. I think publishing such things is the most humble & honorable way to keep contact with the physicians for a pharmaceutical company. Wish you all the best.

Dr. Abu Sayed Md. Mostafa
Choudhury Para, Comilla

It's my pleasure to go through your Medinews Vol: 1, No: 2. It enriched my knowledge about a common but complicated Systemic disease SLE; especially about the new treatment plan. I think GPL will continue such informative service & keep the doctors in touch about the latest advancement of Medical science. All the best.